Retinal Degenerations

Leo A. Kim, MD, PhD, a clinician scientist with surgical expertise and an innovator in the treatment of retinal diseases associated with neovascularization and fibrosis and an Associate Professor of Ophthalmology at Harvard Medical School, will serve as...

This year's Iraty Award for Research in Retinal Diseases honors Petr Baranov, PhD, a scientist at Schepens Eye Research Institute of Mass. Eye and Ear and Assistant Professor of Ophthalmology at Harvard Medical School. The award, which includes a $100,000...

A recent meta-analysis, led by Deeba Husain, MD , suggests that AMD patients present distinct plasma metabolomic profiles, which vary with disease severity. After analyzing blood samples of their 491 patients from two cohorts–one in Boston and one in...

OCU400, a novel gene therapy platform developed by Neena Haider, PhD, Harvard Medical School Associate Professor of Ophthalmology and Associate Scientist at the Schepens Eye Research Institute of Mass. Eye and Ear, and licensed to biopharmaceutical...

A study led by Eleftherios Paschalis, PhD, describes a mechanism by which patients with acute ocular injuries become susceptible to progressive neurodegeneration long after the injury has taken place. Published in Proceedings of National Academy of...